tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Christopher Raymond, 539 are a BUY (82.16%), 108 are a HOLD (16.46%), 9 are a SELL (1.37%).
Analyst Christopher Raymond, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 46.36% that have a potential upside of 46.55% achieved within 261 days.
Christopher Raymond’s has documented 1,273 price targets and ratings displayed on 54 stocks. The coverage is on Healthcare, Consumer Cyclical, Energy, Basic Materials, Technology sectors.
Most recent stock forecast was given on ARDX, Ardelyx at 17-Aug-2026.
Analyst best performing recommendations are on ALXO (ALX ONCOLOGY HOLDINGS).
The best stock recommendation documented was for INO (INOVIO PHARMACEUTICALS) at 3/26/2020. The price target of $96 was fulfilled within 1 day with a profit of $10.2 (11.89%) receiving and performance score of 118.88.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Feb-2026
$325
$40.2 (14.12%)
$300
Buy Since 04-Feb-2020
$288
$3.2 (1.12%)
$288
14 days ago
(09-Oct-2026)
45/45 (100%)
$11.53 (4.17%)
407
Hold Since 06-Jan-2026
$275
$-9.8 (-3.44%)
$260
14 days ago
(09-Oct-2026)
5/5 (100%)
$-1.47 (-0.53%)
76
Buy Since 16-Oct-2020
$300
$15.2 (5.34%)
$280
15 days ago
(08-Oct-2026)
20/21 (95.24%)
$27.58 (10.12%)
441
Buy Since 15-Nov-2023
$290
$5.2 (1.83%)
$285
15 days ago
(08-Oct-2026)
31/32 (96.88%)
$17.58 (6.45%)
251
Which stock is Christopher Raymond most bullish on?
Which stock is Christopher Raymond most reserved on?
What Year was the first public recommendation made by Christopher Raymond?
